Document Detail


Combined use of botulinum toxin type A and B for forehead rhytides: a randomized, double-blind, split-face study.
MedLine Citation:
PMID:  21801115     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: This is the first well-controlled study of the combined use of botulinum toxin type A (BoNT-A) and botulinum toxin type B (BoNT-B) for hyperkinetic lines in forehead.
OBJECTIVE: To evaluate the effectiveness and safety of a mixture of BoNT-A and BoNT-B with that of equipotent BoNT-A alone for treating patients with forehead rhytides.
MATERIALS AND METHODS: Fourteen patients with forehead wrinkles completed this clinical study. On day 0, patients received a mixture of BoNT-A (5 U) and B (500 U) on one side of the forehead and BoNT-A (10 U) symmetrically on the other side. Clinical evaluation was made at the beginning and at weeks 1, 2, 4, 8, 12, and 16. Therapeutic efficacy was evaluated using clinical improvement scale by investigators and the subjective wrinkle assessment by patients.
RESULTS: According to investigator assessment, the differences between the average improvement scores of the two differently treated sides were not statistically significant at all follow-up visits. Moreover, the plateau of the clinical benefit was achieved at week 4.
CONCLUSION: We observed the equivalent efficacy in the mixture of both toxins and BoNT-A alone.
Authors:
Jee-Woong Choi; Choon-Shik Youn; Hi-Tae An; Jong-Yeop Yoo; Jung-Im Na; Kyoung-Chan Park; Sang-Woong Youn; Chang-Hun Huh
Related Documents :
3554565 - A comparative study of cefotetan and metronidazole against metronidazole alone to preve...
10533765 - Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of int...
2105115 - Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazo...
1952835 - Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary p...
25281005 - Impact of left atrial appendage exclusion using an epicardial ligation system (lariat) ...
18283575 - Supplementary pedicle screw fixation in spinal fusion for degenerative spondylolisthesi...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2011-07-31
Journal Detail:
Title:  The Journal of dermatological treatment     Volume:  24     ISSN:  1471-1753     ISO Abbreviation:  J Dermatolog Treat     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-18     Completed Date:  2013-07-17     Revised Date:  2013-11-25    
Medline Journal Info:
Nlm Unique ID:  8918133     Medline TA:  J Dermatolog Treat     Country:  England    
Other Details:
Languages:  eng     Pagination:  126-32     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Botulinum Toxins / therapeutic use*
Botulinum Toxins, Type A / therapeutic use*
Double-Blind Method
Drug Therapy, Combination
Female
Forehead
Humans
Male
Middle Aged
Neuromuscular Agents / therapeutic use*
Skin Aging / drug effects*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Neuromuscular Agents; 0/incobotulinumtoxinA; 0Y70779M1F/rimabotulinumtoxinB; EC 3.4.24.69/Botulinum Toxins; EC 3.4.24.69/Botulinum Toxins, Type A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Leflunomide: dermatologic perspective.
Next Document:  Software for quantifying psoriasis and vitiligo from digital clinical photographs.